AU5654998A - Muteins of obese protein - Google Patents
Muteins of obese proteinInfo
- Publication number
- AU5654998A AU5654998A AU56549/98A AU5654998A AU5654998A AU 5654998 A AU5654998 A AU 5654998A AU 56549/98 A AU56549/98 A AU 56549/98A AU 5654998 A AU5654998 A AU 5654998A AU 5654998 A AU5654998 A AU 5654998A
- Authority
- AU
- Australia
- Prior art keywords
- muteins
- obese protein
- obese
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/5759—Products of obesity genes, e.g. leptin, obese (OB), tub, fat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Biochemistry (AREA)
- Obesity (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Child & Adolescent Psychology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP96119606 | 1996-12-06 | ||
| EP96119606 | 1996-12-06 | ||
| PCT/EP1997/006541 WO1998024896A2 (en) | 1996-12-06 | 1997-11-22 | Muteins of obese protein |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU5654998A true AU5654998A (en) | 1998-06-29 |
Family
ID=8223476
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU56549/98A Abandoned AU5654998A (en) | 1996-12-06 | 1997-11-22 | Muteins of obese protein |
Country Status (8)
| Country | Link |
|---|---|
| AR (1) | AR010333A1 (en) |
| AU (1) | AU5654998A (en) |
| CO (1) | CO4930295A1 (en) |
| HR (1) | HRP970654A2 (en) |
| MA (1) | MA24411A1 (en) |
| PE (1) | PE20399A1 (en) |
| WO (1) | WO1998024896A2 (en) |
| ZA (1) | ZA9710832B (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7208572B2 (en) | 1998-08-21 | 2007-04-24 | Albany Medical College | Leptin-related peptides |
| US6777388B1 (en) | 1998-08-21 | 2004-08-17 | Clf Medical Technology Acceleration Program, Inc. | Leptin-related peptides |
| US6420339B1 (en) * | 1998-10-14 | 2002-07-16 | Amgen Inc. | Site-directed dual pegylation of proteins for improved bioactivity and biocompatibility |
| US8227408B2 (en) | 2005-09-07 | 2012-07-24 | Neurotez, Inc. | Leptin as an anti-amyloidogenic biologic and methods for delaying the onset and reducing Alzheimer's disease-like pathology |
| AU2009248914A1 (en) | 2008-05-21 | 2009-11-26 | Neurotez, Inc. | Methods for Treating Neurodegenerative Disorders Related to Neurofibrillary Tangles |
| AU2009313562B2 (en) | 2008-11-04 | 2012-11-15 | Neurotez, Inc. | Leptin compositions and methods for treating progressive cognitive function disorders resulting from accumulation of neurofibrillary tangles and amlyoid beta |
| JP6174489B2 (en) | 2010-09-28 | 2017-08-02 | アエゲリオン ファーマシューティカルズ,インコーポレイテッド | Highly soluble leptin |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ209246A (en) * | 1983-08-17 | 1989-04-26 | Wellcome Found | Monoclonal hormone antibody formulations which potentiate or mimic hormone administration in vertebrates |
| US6309853B1 (en) * | 1994-08-17 | 2001-10-30 | The Rockfeller University | Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
| EP0725079A1 (en) * | 1995-01-31 | 1996-08-07 | Eli Lilly And Company | Anti-obesity proteins |
| GB9509164D0 (en) * | 1995-05-05 | 1995-06-28 | Smithkline Beecham Plc | Novel compounds |
-
1997
- 1997-11-22 AU AU56549/98A patent/AU5654998A/en not_active Abandoned
- 1997-11-22 WO PCT/EP1997/006541 patent/WO1998024896A2/en not_active Ceased
- 1997-12-01 MA MA24881A patent/MA24411A1/en unknown
- 1997-12-02 PE PE00108697A patent/PE20399A1/en not_active Application Discontinuation
- 1997-12-02 ZA ZA9710832A patent/ZA9710832B/en unknown
- 1997-12-03 HR HRP970654 patent/HRP970654A2/en not_active Application Discontinuation
- 1997-12-04 CO CO97071061A patent/CO4930295A1/en unknown
- 1997-12-04 AR ARP970105715 patent/AR010333A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PE20399A1 (en) | 1999-03-05 |
| AR010333A1 (en) | 2000-06-07 |
| ZA9710832B (en) | 1998-06-08 |
| MA24411A1 (en) | 1998-07-01 |
| HRP970654A2 (en) | 1998-10-31 |
| WO1998024896A3 (en) | 1998-10-01 |
| CO4930295A1 (en) | 2000-06-27 |
| WO1998024896A2 (en) | 1998-06-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU5721798A (en) | Human mage-like protein | |
| AU6030398A (en) | Human proteins | |
| AU4922497A (en) | Interleukin-18-receptor proteins | |
| AU2548097A (en) | Formulations of ob protein | |
| AU6721696A (en) | Cd44-like protein | |
| AU5796298A (en) | Secreted human proteins | |
| AU2557997A (en) | Human cachexia associated protein | |
| AU3902297A (en) | Two human nsp-like proteins | |
| AU4480697A (en) | Human nm23-like protein | |
| AU5355996A (en) | Human chemokine polypeptides | |
| AU4261197A (en) | Human protein kinases | |
| AU5389096A (en) | Human hematopoietic-specific protein | |
| AU4750097A (en) | Human reg i-gamma protein | |
| AU1750997A (en) | Obesity protein formulations | |
| AU5654998A (en) | Muteins of obese protein | |
| AU9017598A (en) | Human frezzled-like protein | |
| AU1705197A (en) | Obesity protein formulations | |
| AU2243997A (en) | Obesity protein formulations | |
| AU2246097A (en) | Obesity protein analog compounds and formulations thereof | |
| AU4422897A (en) | Cross-dimerization of olefins | |
| AU5148098A (en) | Human eosinophil-derived basic protein | |
| AU1747297A (en) | Obesity protein formulations | |
| AU5621798A (en) | Human pathogenesis-related protein | |
| AU4744997A (en) | Novel human phospholemman-like protein | |
| AU4582597A (en) | Therapeutic proteins |